Dynavax Technologies Corporation and GlaxoSmithKline Expand Their...
RKELEY, CA, Oct 21, 2011 -- Dynavax Technologies Corporation announced today the expansion of its worldwide strategic alliance with GlaxoSmithKline focused on toll-like receptor inhibitors.
Join the discussion below, or Read more at BioSpace.
#1 Oct 26, 2011
the ecdysone (insect estrogen) receptor, a ligand-activated transcription factor found in the nuclei of insect cells. This in turn leads to the activation of many other genes and can cause many deseases such as TB!
Add your comments below
|Dynavax Technologies: An Updated View After FDA...||May '16||ELISE||1|
|Hepatitis B Therapeutic Vaccine Appears Safe an... (Feb '11)||Feb '11||BioInvestor||2|
|Dynavax Appoints Chief Medical Officer (Jun '09)||Jun '09||andrew j langham||1|
|Hay Fever Vaccine Holds Promise, Say Scientists (Oct '06)||Oct '06||John Lipshield moboy||1|
Find what you want!
Search Dynavax Technologies Forum Now
Copyright © 2016 Topix LLC